US2016228460A1PendingUtilityA1

Nitroxyl progenitors in the treatment of heart failure

62
Assignee: THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVER AND AGRICULTURAL AND MECH COLLEGEPriority: Aug 21, 2002Filed: Apr 20, 2016Published: Aug 11, 2016
Est. expiryAug 21, 2022(expired)· nominal 20-yr term from priority
A61K 33/00A61K 31/655A61P 9/04A61K 31/16A61K 31/13
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Administration of an HNO/NO − donating compound, such as Angeli's salt, increases myocardial contractility while concomitantly lowering left ventricular preload in subjects experiencing heart failure. Moreover, administration of the HNO/NO − donating compound isopropylamine (IPA)/NO (Na(CH 3 ) 2 CHNHN(O)NO) surprisingly exhibited positive inotropic effects in subjects experiencing heart failure that were superior to those caused by the HNO/NO − donating compound Angeli's salt. Additionally, in contrast to the effects observed with NO· donors, administration of an HNO/NO − donor in combination with a positive inotropic agent did not impair the positive inotropic effect of the positive inotropic agent. Further, HNO/NO − exerts its positive inotropic effect independent of the adrenergic system, increasing contractility even in subjects receiving beta-antagonist therapy.

Claims

exact text as granted — not AI-modified
1 . A method of treating heart failure comprising,
 Administering to a subject experiencing heart failure, a therapeutically effective dose of at least one nitroxyl donating compound and at least one positive inotropic compound, wherein the does is effective to increase myocardial contractility.   
     
     
         2 - 25 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.